Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Total Current Liabilities (2016 - 2025)

CV Sciences' Total Current Liabilities history spans 14 years, with the latest figure at $4.8 million for Q3 2025.

  • For Q3 2025, Total Current Liabilities fell 22.09% year-over-year to $4.8 million; the TTM value through Sep 2025 reached $4.8 million, down 22.09%, while the annual FY2024 figure was $6.1 million, 0.1% changed from the prior year.
  • Total Current Liabilities for Q3 2025 was $4.8 million at CV Sciences, down from $5.7 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $14.5 million in Q4 2021 and bottomed at $4.8 million in Q3 2025.
  • The 5-year median for Total Current Liabilities is $6.1 million (2023), against an average of $8.3 million.
  • The largest annual shift saw Total Current Liabilities increased 0.87% in 2021 before it tumbled 55.95% in 2023.
  • A 5-year view of Total Current Liabilities shows it stood at $14.5 million in 2021, then decreased by 7.93% to $13.3 million in 2022, then crashed by 54.07% to $6.1 million in 2023, then decreased by 0.1% to $6.1 million in 2024, then dropped by 21.66% to $4.8 million in 2025.
  • Per Business Quant, the three most recent readings for CVSI's Total Current Liabilities are $4.8 million (Q3 2025), $5.7 million (Q2 2025), and $5.3 million (Q1 2025).